BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17486143)

  • 1. Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor.
    Bailey RJ; Hay DL
    Br J Pharmacol; 2007 Jul; 151(5):678-87. PubMed ID: 17486143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors.
    Conner AC; Hay DL; Simms J; Howitt SG; Schindler M; Smith DM; Wheatley M; Poyner DR
    Mol Pharmacol; 2005 Jan; 67(1):20-31. PubMed ID: 15615699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
    Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
    Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
    Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation is important for binding to human calcitonin receptors.
    Ho HH; Gilbert MT; Nussenzveig DR; Gershengorn MC
    Biochemistry; 1999 Feb; 38(6):1866-72. PubMed ID: 10026267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide stimulates cyclic AMP accumulation via the porcine calcitonin receptor.
    Christmanson L; Westermark P; Betsholtz C
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1226-35. PubMed ID: 7802654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
    Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
    Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human orphan calcitonin receptor-like structure.
    Flühmann B; Muff R; Hunziker W; Fischer JA; Born W
    Biochem Biophys Res Commun; 1995 Jan; 206(1):341-7. PubMed ID: 7818539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
    Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
    Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.
    Stitham J; Arehart E; Gleim SR; Li N; Douville K; Hwa J
    Br J Pharmacol; 2007 Oct; 152(4):513-22. PubMed ID: 17704830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor.
    Conner AC; Simms J; Conner MT; Wootten DL; Wheatley M; Poyner DR
    Biochemistry; 2006 Oct; 45(43):12976-85. PubMed ID: 17059214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.
    Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Kato J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):380-5. PubMed ID: 20074556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.
    Hay DL; Christopoulos G; Christopoulos A; Poyner DR; Sexton PM
    Mol Pharmacol; 2005 May; 67(5):1655-65. PubMed ID: 15692146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
    Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
    Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor.
    Ma JN; Currier EA; Essex A; Feddock M; Spalding TA; Nash NR; Brann MR; Burstein ES
    Biochem Pharmacol; 2004 Apr; 67(7):1279-84. PubMed ID: 15013843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.